Advertisement

Oncology

Advertisement

Though patient enrollment in clinical trials for cancer therapies has slowed as a result of the COVID-19 pandemic, and some institutions have halted trials altogether, other trials are continuing with modified protocols, according to STAT News.

The cost of cancer-related care is projected to increase 34 percent in the next decade, according to a study published in Cancer Epidemiology, Biomarkers & Prevention. 

Advertisement